Review of fluconazole properties and analytical methods for its determination

Critical Reviews in Analytical Chemistry

Volumn 41, Issue 3, 2011, Pages 270-279

  Corrêa, Josilene Chaves Ruela ^a   Salgado, Hérida Regina Nunes ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Faculdade de Ciências Farmacêuticas de Araraquara   (Brazil)

Author keywords

Analytical methods; Fluconazole; Review

Indexed keywords

ABDOMINAL PAIN; ANALYTICAL METHOD; ANTI-FUNGAL; CANDIDA SP; FLUCONAZOLE; FUNGAL CELLS; GASTROINTESTINAL TRACT; METHODS OF ANALYSIS; OROPHARYNGEAL; PHARMACEUTICAL FORMULATION; PHYSICOCHEMICAL PROPERTY; SELECTIVE INHIBITORS; THIN LAYERS;

CELL MEMBRANES; CYTOLOGY; ETHANOL; GAS CHROMATOGRAPHY; PATIENT TREATMENT;

LIQUID CHROMATOGRAPHY;

ANALYTICAL METHOD; BODY FLUID; DRUG; ERGOSTEROL; PHYSICOCHEMICAL PROPERTY;

CANDIDA;

EID: 79960852642     PISSN: 10408347     EISSN: 15476510     Source Type: Journal    
DOI: 10.1080/10408347.2011.588924     Document Type: Review

References (59)

1. Abdel-Moety, E. M.; Khattab, F. I.; Kelani, K. M.; Aboual-Alamein, A. M. Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations. Farmaco. 2002, 57, 931-938.
2. Alkhamis, K. A.; Obaidat, A. A.; Nuseirat, A. F. Solid-State characterization of fluconazole. Pharm. Dev. Technol. 2002, 7(4), 491-503.
3. Ayub, A. C.; Vianna-Soares, C. D.; Ferreira, L. A. Fluconazole method validation by RP-HPLC for determination in biological skin matrices. J. Chromatogr. Sci. 2007, 45(5), 286-290.
4. Bennett, E. J. Antimicrobianos (continuação) Agentes antifúngicos. In As bases farmacoĺogicas da terapêutica; Gilman, A. G.; Goodman, L. S.; Gilman A., Ed.; McGraw-Hill Interamericana do Brasil: Rio de Janeiro, 2003; pp 975-979.
5. Bergold, A. M.; Georgiadis, S. Novidades em f́armacos antifúngicos: uma revisão. Visão Acadêmica 2004, 5(2), 159-172.
6. Bharathi, D. V.; Hoth, K. K.; Sagar, P. V. V.; Kumar, S. S.; Reddy, P. R.; Naidu, A.; Mullangi, R. Development and validation of a highly sensitive and robust LCMS/MS with electrospray ionization method for simultaneous quantitation of itraconazole and hydroxyitraconazole in human plasma: application to a bioequivalence study. J. Chromatogr. B 2008, 868, 70-76.
7. Brazil. Agência Nacional de Vigilância Sanit́aria. http://www.anvisa.gov.br (accessed on 01/21/09).
8. Carrasco-Portugal, M. del C.; Flores-Murrieta, F. J. Gender differences in the oral pharmacokinetics of fluconazole. Clin. Drug Investig. 2007, 27(12), 851-855.
9. Carrillo-Mũnoz, A. J.; Giusiano, G.; Ezkurra, P. A.; Quindós, G. Antifungal agents: Mode of action in yeast cells. Rev. Esp. Quimioterap. 2006, 19(2), 130-139.
10. Cociglio, M.; Brandlssou, S.; Alric, R.; Bressolle, F. High-performance liquid chromatographic determination of fluconazole in plasma. J. Chromatogr. Biomed. 1996, 686, 11-17.
11. Coelho, H.; Matinattil, A. N. F.; Aráujo, M. B.; Bergold, A. M.; Bueno, F. Análise qumico-farmacêutica do fluconazol e especialidade farmac êutica cápsula. Rev. Bras. Cienc. Farm. 2004, 40(2), 235-246.
12. Conrado, D. J.; Palma, E. C.; Fraga, C. A. M.; Barreiro, E. J.; Rates, S. M. K.; Dalla Costa, T. Development and validation of a LCMS/ MS method with electrospray ionization for determination of LASSBio-579 in rat plasma. J. Pharm. Biomed. 2007, 43, 677-682.
13. Dash, A. K.; Elmquist, W. F. Fluconazole. In Analytical Profiles of Drug Substances and Excipients; Brittain, H. G., Ed.; Academic Press: San Diego, 2001; Vol. 27; pp 67-113.
14. Debruyne, D.; Ryckelynck, J. P.; Bigot, M. C.; Moulin, M. Determination of fluconazole in biological fluids by capillary column gas chromatography with a nitrogen detector. J. Pharm. Sci. 1988, 77(6), 534-535.
15. Dentinger, P. J.; Swenson, C. F. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes. Ann. Pharmacother. 2009, 43(3), 485-489.
16. Desai, S. R.; Shaikh, M. M.;Dharwadkar, S. R. Thermoanalytical study of polymorphic transformation in Fluconazole drug. Thermochim. Acta 2003, 399, 81-89.
17. Dongre, V. G.; Karmuse, P. P.; Ghugare, P. D.; Salunke, S. M.; Panda, N.; Kumar, A. A. Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS. J. Pharm. Biomed. 2006, 42(3), 334-340.
18. Dongre, V. G.; Ghugare, P. D.; Karmuse, P. P.; Soudagar, S. R.; Panda, N.;Kumar, A. A. Isolation and structural identification of an impurity in fluconazole bulk drug substance. J. Pharm. Biomed. 2007, 45(3), 422-429.
19. Egle, H.; Trittler, R.; Kümmerer, K. New, rapid, fully automatedmethod for determination of fluconazole in serum by column-switching liquid chromatography. Ther. Drug Monit. 2004, 26(4), 425-431.
20. Farmacopéia Brasileira, 4th ed. Atheneu: São Paulo, 2005.
21. Gu, X. J.; Jiang,W. Characterization of polymorphic forms of fluconazole using Fourier-transform raman spectroscopy. J. Pharm. Sci. 1995, 84, 1438-1441.
22. Heeren, F.; Tanner, R.; Theurillat, R.; Thormann, W. Determination of fluconazole in human plasma by micellar electrokinetic capillary chromatography with detection at 190 nm. J. Chromatogr. A 1996, 745, 165-172.
23. Holler, S.; Valenta, C. Effect of selected fluorinated drugs in a ringing gel on rheological behavior and skin permeation. Eur. J. Pharm. Biopharm. 2007, 66, 120-126.
24. Hurtado, F. K.; Souza, M. J.;Melo, J.; Rolim, C.M. B.Microbiological assay and hplc method for the determination of fluconazole in pharmaceutical injectable formulations. Lat. Am. J. Pharm. 2008, 27(2), 224-228.
25. Kim, S.-S.; Im, H.-T.; Kang, I.-M.; Lee, H.-S.; Lee, H.-W.; Cho, S.-H.; Kim, J.-B.; Lee, K.-T.An optimized analytical method of fluconazole in human plasma by high-performance liquid chromatography with ultraviolet detection and its application to a bioequivalence study. J. Chromatogr. B 2007, 852 (1-2), 174-179.
26. Koks, C. H. W.; Rosing, H.; Meenhorst, P. L.; Bult, A.; Beijnen, J. H. High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients. J. Chromatogr. Biomed. 1995, 663, 345-351.
27. Lee, C. H.;Yeh, P.H.; Tsai, T.H. Hepatobiliary excretion of fluconazole and its interaction with cyclosporin A in rat blood and bile using microdialysis. Int. J. Pharm. 2002, 241, 367-373.
28. Lopes, C. C. G. O.; Salgado, H. R. N. Development of a validated stability-indicating LC assay and stress degradation studies of linezolid in tablets. Chromatographia 2009, 69, S129-S135.
29. Majcherczyk, P. A.; Moreillon, P.; Decosterd, L. A.; Sanglard, D.; Bille, J.; Glauser, M. P.; Marchetti, O. Single-step extraction of fluconazole from plasma by ultra-filtration for the measurement of its free concentration by high performance liquid chromatography. J. Pharm. Biomed. 2002, 28, 645-651.
30. Marciniec, B.; Dettlaff, K.; Jaroszkiewicz, E.; Bafeltowskac, J. Radiochemical stability of fluconazole in the solid state. J. Pharm. Biomed. 2007, 43, 1876-1880.
31. Martinez, R. Atualizaç ão no uso de agentes antifúngicos. J. Bras. Pneumol. 2006, 32(5), 449-460.
32. Mathy, F.-X.; Vroman, B.; Ntivunwa, D.; Winne, A. J.; Verbeeck, R. K.; Préat, V. On-line determination of fluconazole in blood and dermal rat microdialysates by microbore high-performance liquid chromatography. J. Chromatogr. B 2003, 787, 323-331.
33. McLachlan, A. J.; Gross, A. S.; Beal, J. L.; Minns, I.; Tett, S. E. Analytical Validation for a Series of Marker Compounds Used to Assess Renal Drug Elimination Processes. Ther. Drug Monit. 2001, 23(1), 39-46.
34. Moraes, L. A.; Lerner, F. E.; Moraes, M. E. A.; Moraes, M. O.; Corso, G.; De Nucci, G. Fluconazole Bioequivalence Study: Quantification by Tandem Mass Spectrometry. Ther. Drug Monit. 1999, 21(2), 200-207.
35. Moreno, A. H.; Salgado, H. R. N. Development and validation of HPLC method for determination of ceftazidime. Journal of AOAC International. J. AOAC Int. 2008, 91(4), 739-743.
36. Moretti, M. L. A importância crescente das infecç ões fúngicas. Rev. Panam. Infectol 2007, 9(2), 8-9.
37. O'Neil, M. J. et al. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 14th ed., Version 14.6; Merck: Whitehouse Station, N.J., 2006, 2010.
38. Park, J. S.; Yu, K. A.; Kang, T. H.; Kim, S.; Suh, Y. G. Discovery of novel indazole-linked triazoles as antifungal agents. Bioorg. Med. Chem. Lett. 2007a, 17, 3486-3490.
39. Park, H. J.; Kim, M.-S.; Lee, S.; Kim, J.-S.; Woo, J.-S.; Park, J.-S.; Hwang, S.-J. Recrystallization of fluconazole using the supercritical antisolvent (SAS) process. Int. J. Pharm. 2007b, 328, 152-160.
40. Pereira, D. G. Importância do metabolismo no planejamento de f́armacos. Quim. Nova 2007, 30(1), 171-177.
41. Porta, V.; Chang, K. H.; Storpirtis, S. Evaluation of the bioequivalenceof capsules containing 150 mg of fluconazole. Int. J. Pharm. 2005, 288(1), 81-86.
42. Porta, V.; Yamamichi, E.; Storpirtis, S. Avaliaç ão biofarmacêutica in vitro de ćapsulas de fluconazol. Rev. Bras. Cienc. Farm. 2002, 38(3), 333-343.
43. Richardson, K.; Brammer, K. W.; Marriott, M. S.; Troke, P. F. Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrob. Agents Chemother. 1985, 27(5), 832-835.
44. Salgado, H. R. N.; Roncari, A. F. F. Microbiological assay for determination of azithromycin in ophthalmic solutions. Acta Pharmacol. Sin. 2005, 40(6), 544-549.
45. Salgado, H. R. N.; Lopes, C. C. G. O.; Lucchesi, M. B. B. Microbiological assay for gatifloxacin in pharmaceutical formulations. J. Pharm. Biomed. 2006, 40(2), 443-446.
46. Salgado, H. R. N.; Moreno, A. H.; Garg, S. LC-DAD Determination of Fleroxacin in Bulk and Pharmaceutical Dosage Forms. Chromatographia 2009, 69, S237-S240.
47. Sasongko, L.; Williams, K.M.; Day, R.O.; McLachlan, A. J. A. Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques. Brit. J. Clin. Pharmacol. 2003, 56, 551-561.
48. Sun, S.; Lou, H.; Gao, Y.; Fan, P.; Ma, B.; Ge, W.; Wang, X. Liquid chromatographytandem mass spectrometric method for the analysis of fluconazole and evaluation of the impact of phenolic compounds on the concentration of fluconazole in Candida albicans. J. Pharm. Biomed. 2004, 34, 1117-1124.
49. Telles Filho, F. Q. Posaconazol: um novo triaźolico de segunda geraç ão. Pratica Hospitalar 2007, 52, 58-60.
50. Tozo, G. C. G.; Salgado, H. R. N. Determination of lomefloxacin in raw material and tablet preparations by liquid chromatography. Journal of AOAC International. J. AOAC Int. 2006, 89(5), 1305-1308.
51. Tozo, G. C. G.; Salgado, H. R. N. Microbiological assay for cefoxitin sodium in dosage form. J. AOAC Int. 2007, 90(2), 452-455.
52. U.S. Food and Drug Administration. 2010. Dissolution Methods http://www.accessdata.fda.gov/scripts/cder/dissolution/dspSearchResultsDissolutions.cfm (accessed 5/31/11).
53. United States Pharmacopeia, 31st ed., National Formulary XXVI; US Pharmacopoeial Convention: Rockville, Md., 2008.
54. Vaden, S. L.; Heit, M. C.; Hawkins, E. C.; Manaugh, C.; Riviere, J. E. Fluconazole in cats: Pharmacokinetics following intravenous and oral administration and penetration into cerebrospinal fluid, aqueous humor and pulmonary epithelial lining fluid. J. Vet. Pharmacol. Ther. 1997, 20, 181-186.
55. Wallace, J. E.; Harris, S. C.; Gallegos, J.; Foulds, G.; Chen, T. J.; Rinaldi, M. G. Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column. Antimicrob. Agents Chemother. 1992, 36(3), 603-606.
56. Wattananat, T.; Akarawut,W. Validated HPLC method for the determination of fluconazole in human plasma. Biomed. Chromatogr. 2006, 20(1), 1-3.
57. Yamreudeewong, W.; Lopez-Anaya, A.; Rappaport, H. Rappaport, H. Stability of fluconazole in an extemporaneously prepared oral liquid. Am. J. Hosp. Pharm. 1993, 50(11), 2366-2367.
58. Youdim, K. A.; Lyons, R.; Payne, L.; Jones, B. C.; Saunders, K. An automated, high-throughput, 384 well cytochrome P450 cocktail IC50 assay using a rapid resolution LCMS/MS end-point. J. Pharmaceut. Biomed. 2008, 48, 92-99.
59. Zhang, S.; Mada, S. R.; Torch, M.; Goval, R. K.; Venkataramanan, R. Development and validation of a high-performance liquid chromatographic assay for the determination of fluconazole in human whole blood using solid phase extraction. Ther. Drug Monit. 2008, 30(3), 314-319.